{"doi":"10.18632/oncotarget.13274","title":"Refractory pituitary adenoma: a novel classification for pituitary tumors","abstract":null,"journal":"Oncotarget","year":2016,"id":42341,"datarank":1.5045396620787177,"base_score":3.784189633918261,"endowment":3.784189633918261,"self_citation_contribution":0.5676284450877392,"citation_network_contribution":0.9369112169909785,"self_endowment_contribution":0.5676284450877392,"citer_contribution":0.9369112169909785,"corpus_percentile":null,"corpus_rank":null,"citation_count":43,"citer_count":29,"citers_with_citation_signal":24,"citers_with_endowment":24,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":202827,"name":"Ming Feng","orcid":null,"position":1,"is_corresponding":false},{"id":202828,"name":"Xiaohai Liu","orcid":null,"position":2,"is_corresponding":false},{"id":202829,"name":"Sihai Ma","orcid":null,"position":3,"is_corresponding":false},{"id":202830,"name":"Bowen Sun","orcid":null,"position":4,"is_corresponding":false},{"id":202831,"name":"Xinjie Bao","orcid":null,"position":5,"is_corresponding":false},{"id":202832,"name":"Yong Yao","orcid":null,"position":6,"is_corresponding":false},{"id":202833,"name":"Kan Deng","orcid":null,"position":7,"is_corresponding":false},{"id":22277,"name":"Yu Wang","orcid":"0000-0003-4635-7059","position":8,"is_corresponding":false},{"id":202834,"name":"Bing Xing","orcid":"0000-0002-3864-5168","position":9,"is_corresponding":false},{"id":202835,"name":"Wei Lian","orcid":null,"position":10,"is_corresponding":false},{"id":202836,"name":"Dingrong Zhong","orcid":null,"position":11,"is_corresponding":false},{"id":202837,"name":"Wenbin Ma","orcid":null,"position":12,"is_corresponding":false},{"id":202838,"name":"Renzhi Wang","orcid":null,"position":13,"is_corresponding":false},{"id":202826,"name":"Congxin Dai","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.784189633918261,"endowment":3.784189633918261,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"27845901","pmcid":"PMC5347795","openalex_id":"https://openalex.org/W2554297994","authors":[],"funders":[],"total_grants":0,"fwci":3.3713,"citation_percentile":0.92747278,"influential_citations":3,"citation_trend":[{"year":2017,"count":2},{"year":2018,"count":6},{"year":2019,"count":6},{"year":2020,"count":7},{"year":2021,"count":5},{"year":2022,"count":4},{"year":2023,"count":4},{"year":2024,"count":4},{"year":2025,"count":3},{"year":2026,"count":2}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13274&path%5B%5D=42131","host_type":"journal"},{"url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13274&path%5B%5D=42131","host_type":"GOLD"},{"url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13274&path%5B%5D=42131","host_type":"publisher"},{"url":"https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.13274","host_type":"publisher"},{"url":"https://doi.org/10.18632/oncotarget.13274","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/27845901","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5347795","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC5347795","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC5347795?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Pituitary Gland Disorders and Treatments","Glioma Diagnosis and Treatment","Adrenal and Paraganglionic Tumors","Medicine","Adenoma","Adult","Aged","Antineoplastic Agents, Alkylating","Biopsy","Cell Proliferation","Dacarbazine","Disease Progression","Drug Resistance, Neoplasm","Fatal Outcome","Female","Humans","Ki-67 Antigen","Magnetic Resonance Imaging","Male","Middle Aged","Neoplasm Invasiveness","Neoplasm Recurrence, Local","Pituitary Neoplasms","Salvage Therapy","Temozolomide","Terminology as Topic","Time Factors","Treatment Outcome","Tumor Burden"],"mesh_terms":["Temozolomide","Adenoma","Adult","Aged","Biopsy","Dacarbazine","Female","Humans","Magnetic Resonance Imaging","Male","Middle Aged","Neoplasm Invasiveness","Neoplasm Recurrence, Local","Terminology as Topic","Pituitary Neoplasms","Time Factors","Salvage Therapy","Treatment Outcome","Fatal Outcome","Disease Progression","Antineoplastic Agents, Alkylating","Drug Resistance, Neoplasm","Ki-67 Antigen","Tumor Burden","Cell Proliferation"],"keywords":["Pituitary adenoma","Medicine","Refractory (planetary science)","Pituitary tumors","Pathological","Temozolomide","Adenoma","Pituitary neoplasm","Pituitary gland","Acromegaly","Salvage therapy","Pathology","Internal medicine","Oncology","Chemotherapy","Biology","Resistance","Recurrence","Refractory","pituitary adenomas","Aggressive"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"No poverty"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-14T02:25:35.238653Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}